The doxorubicin-loaded, mesothelin-targeted APMS (APMS-MB-DOX) were then administered via intraperitoneal (i.p.)injection in SCID mice carrying xenografts of human HMESO mesothelioma cells. Here, MSLN is linked to mesothelioma.